Integrating data augmentation and BERT-based deep learning for predicting alpha-glucosidase inhibitors derived from Black Cohosh
- PMID: 40866460
- PMCID: PMC12391535
- DOI: 10.1038/s41598-025-14699-1
Integrating data augmentation and BERT-based deep learning for predicting alpha-glucosidase inhibitors derived from Black Cohosh
Abstract
Diabetes remains one of the critical health issues worldwide, and its prevalence is gaining motion due to prevailing factors such as obesity and a sedentary lifestyle. Traditional herbal medications and natural products, particularly enzyme inhibitors, such as alpha-glucosidase, serve as promising alternatives. This study attempted to identify potent alpha-glucosidase inhibitors by including data augmentation in deep-learning modeling. To achieve the aim, various data augmentation techniques were generated from diverse SMILES strings and augmented deep learning model performances through improved data variability. Fine-tuning of pre-trained models from the Hugging Face repository was performed, and among all, it was shown that the performance of PC10M-450k was the best recall. Further applications consider the model identified as PC10M-450 K. With this model, it was identified actaeaepoxide 3-O-xyloside from Black Cohosh was a potential inhibitor. Further molecular docking and MD simulations presented this compound to interact stably with the enzyme and possess a high inhibition probability when compared to acarbose. The results of insilico drug discovery displayed that actaeaepoxide 3-O-xyloside is pointed out to be a potential candidate for diabetes therapy. In conclusion, the role of augmentation techniques and pre-trained models was also emphasized in the presented investigation to accelerate drug discovery toward more effective therapeutic solutions.
Keywords: Alpha-glucosidase inhibitor; BERT-based model; Data augmentation; Deep learning; Drug discovery; Natural compounds.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Ethical approval and consent to participate: Not applicable.
Figures










Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Identification of specialized metabolites from Artocarpus lacucha as potent α-glucosidase and acetylcholinesterase inhibitors: enzyme kinetic, in vitro and in silico study.J Nat Med. 2025 Jul;79(4):896-912. doi: 10.1007/s11418-025-01904-8. Epub 2025 May 6. J Nat Med. 2025. PMID: 40329121
-
Design and synthesis of novel quinoline-piperazines fused to a phenylhydrazinecarbothioamide scaffold as promising α-glucosidase inhibitors with anti-diabetic potential.Future Med Chem. 2025 Jun;17(11):1217-1227. doi: 10.1080/17568919.2025.2521252. Epub 2025 Jul 16. Future Med Chem. 2025. PMID: 40667753
-
The effectiveness of using non-traditional teaching methods to prepare student health care professionals for the delivery of mental state examination: a systematic review.JBI Database System Rev Implement Rep. 2015 Aug 14;13(7):177-212. doi: 10.11124/jbisrir-2015-2263. JBI Database System Rev Implement Rep. 2015. PMID: 26455855
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
References
-
- Gujral, U. P., Weber, M. B., Staimez, L. R. & Narayan, K. M. V. Diabetes among non-overweight individuals: an emerging public health challenge. Curr Diab Rep10.1007/s11892-018-1017-1 (2018). - PubMed
-
- Standl, E., Khunti, K., Hansen, T. B. & Schnell, O. The global epidemics of diabetes in the 21st century: Current situation and perspectives. Eur J Prev Cardiol.10.1177/2047487319881021 (2019). - PubMed
-
- Sati, P. et al. Gut microbiota targeted approach by natural products in diabetes management: an overview. Curr Nutr. Rep10.1007/s13668-024-00523-1 (2024). - PubMed
-
- Gurib-Fakim, A. Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol Aspects Med Published Online. 10.1016/j.mam.2005.07.008 (2006). - PubMed
-
- Yusuf, B. O., Abdulsalam, R. A. & Sabiu, S. Diabetes Treatment and Prevention Using Herbal Medicine. (2023). 10.1007/978-3-031-21973-3_43-1
MeSH terms
Substances
LinkOut - more resources
Full Text Sources